Top FDA official reflects on compliance actions in 2022
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy